The leading Supreme Court scientific evidence case. Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1995), 516 U.S. 869 (1996). See 1995 WL 17035597, 1995 WL 17035598, 1993 WL 445386, 1993 WL 13006376, 1993 WL 13006390, 1992 WL 12006442, 1992 WL 12006533, 1992 WL 541269, 1992 WL 12006520 (briefs) (U.S. Supreme Court).
A group of amici medical researchers in a class action against a pharmaceutical company and three of its executives alleging that defendants violated federal securities laws by failing to disclose material information regarding one of the company’s products. Matrixx Initiatives, Inc. v. Siracusano, 131 S.Ct. 1309 (2011).
Comments to the US Environmental Protection Energy on behalf of Peabody Energy regarding proposed rules for EPA’s “Clean Power Plan.”
Comments to the US Environmental Protection Energy on behalf of biofuels companies regarding Proposed Standards for the Renewable Fuel Standard Program.
A group of institutional investors in a case presenting the question whether the District Court erred in excluding Plaintiffs’ damages expert under Fed. R. Evid. 702 and Daubert. Teachers Retirement System of Louisiana v. Pfizer, Inc., No. 14-2853-CV (CA2).